Last reviewed · How we verify
NCT03543761
Low-intensity Shockwave Therapy for Non-bacterial Prostatitis/Pelvic Pain Syndrome
NA trial testing Dornier Aries 2 device in Chronic Prostatitis in 45 participants. Completed in 20 December 2019.
2 September 2019
Quick facts
| Lead sponsor | Institute for the Study of Urological Diseases, Greece |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 11 June 2018 |
| Primary completion | 2 September 2019 |
| Estimated completion | 20 December 2019 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Dornier Aries 2 device
- Dornier Aries 2 device
- Dornier Aries 2 device
Conditions studied
- Chronic Prostatitis — all drugs for Chronic Prostatitis →
Sponsor
Institute for the Study of Urological Diseases, Greece
Who can join
Adults 18 to 60, male only, with Chronic Prostatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to investigate and compare the treatment efficacy and safety of ESWT vs sham treatment for CP/CPPS patients.This is a triple-blind, randomized, parallel group sham-controlled clinical study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03543761
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Prostatitis
Currently open trials in the same condition.
- NCT06299683 — Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment · NA · recruiting
- NCT06287970 — TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS · NA · recruiting
- NCT06345014 — The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome · Phase 4 · recruiting
Other Institute for the Study of Urological Diseases, Greece trials
Trials by the same sponsor.
- NCT04549389 — The Ideal LiST Session Frequency Protocol for CPPS Treatment · NA · completed
- NCT04050020 — Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function · Phase 2, PHASE3 · completed
- NCT03641846 — Low-intensity Shockwave Therapy (LiST) for the Treatment of Mild and Mild-to-moderate Vasculogenic Erectile Dysfunction · NA · completed
- NCT03112499 — The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury · NA · completed
- NCT03518983 — Low-intensity Shockwaves Therapy for the Treatment of Patients With Moderate Vasculogenic Erectile Dysfunction · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03543761 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute for the Study of Urological Diseases, Greece
- Last refreshed: 2 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543761.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing